Cost-effectiveness Analysis Of Idursulfase For The Treatment Of Hunter Syndrome In A Tertiary Referral Centre For Rare Diseases In Malaysia: A Partitioned Survival Model Approach

Hunter syndrome (MPS-II) is among the costliest life-long genetic conditions associated with a substantial burden of illness and its significant impact on Malaysia's health systems, families, and society. There needs to be more studies demonstrating its value for money incorporating long-term e...

Description complète

Détails bibliographiques
Auteur principal: Mustaffa, Khairu Hazwan
Format: Thèse
Langue:anglais
Publié: 2024
Sujets:
Accès en ligne:http://eprints.usm.my/62056/

Documents similaires